Correction to Biogen Actemra Biosimilar Article
December 09 2022 - 9:41AM
Dow Jones News
Biogen Inc. said the U.S. Food and Drug Administration has
accepted its application seeking approval of BIIB800, a proposed
biosimilar to Actemra. "Biogen: FDA Accepts Application for Actemra
Biosimilar," at 7:50 a.m. ET, incorrectly said the European
Medicines Agency had accepted the application.
(END) Dow Jones Newswires
December 09, 2022 09:26 ET (14:26 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Jul 2023 to Jul 2024